Moataz Ellithi

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Topics

St Segment Elevation Myocardial Infarction

Drug Administration

Acute Lymphoblastic Leukemia

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer gene therapy

Molecular cancer research : MCR

Case reports in infectious diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Magdi Elsallab, Moataz Ellithi, Matthew A Lunning, Christopher R D'Angelo, Jihyun Ma, Miguel-Ángel Perales, Matthew Frigault, Marcela V Maus
Second primary malignancies after commercial CAR T-cell therapy: analysis of the FDA Adverse Events Reporting System. Blood 143 (20) (2024)
Magdi Elsallab, Moataz Ellithi, Susanne Hempel, Hisham Abdel-Azim, Mohamed Abou-El-Enein
Long-term response to autologous anti-CD19 chimeric antigen receptor T cells in relapsed or refractory B cell acute lymphoblastic leukemia: a systematic review and meta-analysis. Cancer gene therapy (2023)
Magdi Elsallab, Moataz Ellithi, Susanne Hempel, Hisham Abdel-Azim, Mohamed Abou-El-Enein
Long-term response to autologous anti-CD19 chimeric antigen receptor T cells in relapsed or refractory B cell acute lymphoblastic leukemia: a systematic review and meta-analysis. Cancer gene therapy (2023)
Jonathan Q Trinh, Moataz Ellithi, Nicole A Shonka, Raymond C Bergan
FDA Approval Summary: Belzutifan for VHL Disease Tumors-Letter. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (3) (2023)
Jonathan Q Trinh, Moataz Ellithi, Nicole A Shonka, Raymond C Bergan
FDA Approval Summary: Belzutifan for VHL Disease Tumors-Letter. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (3) (2023)
Jonathan Q Trinh, Moataz Ellithi, Nicole A Shonka, Raymond C Bergan
FDA Approval Summary: Belzutifan for VHL Disease Tumors-Letter. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (3) (2023)
Hafez Mohammad Ammar Abdullah, Mansi Oberoi, Abdelmohaymin Abdalla, Smitha Narayana Gowda, Moataz Ellithi
Yersinia enterocolitica Prosthetic Joint Septic Arthritis Successfully Treated with Ceftriaxone. Case reports in infectious diseases 2021 (2021)
Moataz Ellithi, Jordan Baye, Russell A Wilke
CYP2C19 genotype-guided antiplatelet therapy: promises and pitfalls. Pharmacogenomics 21 (12) (2020)
Rahmat K Sikder, Moataz Ellithi, Robert N Uzzo, David J Weader, Alexander L Metz, Ali Behbahani, Erica R McKenzie, Wafik S El-Deiry, Philip H Abbosh
Differential Effects of Clinically Relevant N- versus C-Terminal Truncating CDKN1A Mutations on Cisplatin Sensitivity in Bladder Cancer. Molecular cancer research : MCR 19 (3) (2020)